Skip to search.
 TSX Down 0.02% TSX Ventures Up 0.42%

More On AEZS

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Aeterna Zentaris Inc. (AEZS)

-NasdaqCM
0.30 Down 0.01(4.54%) May 22, 3:59PM EDT
Add to Portfolio
Prev Close:0.32
Open:0.32
Bid:0.27 x 600
Ask:N/A
1y Target Est:1.43
Beta:2.06
Next Earnings Date:N/A
Day's Range:0.29 - 0.33
52wk Range:0.27 - 1.54
Volume:4,351,243
Avg Vol (3m):3,036,620
Market Cap:27.26M
P/E (ttm):N/A
EPS (ttm):-0.28
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
AEZSDown 4.54%27.26M
CELGDown 0.09%92.08B
ENMD 0.00%N/A

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2,595.69
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.33
Quarterly EPS Est (Jun-15) :-0.08
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing novel treatments in oncology, endocrinology, and women's health. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback